
ENYO Pharma is a clinical stage Biotech with a unique drug discovery platform inspired by viruses.
NYO Pharma is a clinical stage Biotech with a unique drug discovery platform inspired by viruses.
The company is conducting three Phase 2 with its lead compound Vonafexor (EYP001, a non-Bile Acid FXR agonist) in Chronic Hepatitis B and in NASH.
Several additional innovative drug discovery programs are progressing speedily towards non-Clinical Development; their human targets being yet untapped by Pharma’s, these programs can moreover be developed for various indications (metabolic diseases, oncology…).
Source : Données publiques des entreprises (INSEE, RNE) · vérifié le 22/09/2026
NYO Pharma is a clinical stage Biotech with a unique drug discovery platform inspired by viruses.
The company is conducting three Phase 2 with its lead compound Vonafexor (EYP001, a non-Bile Acid FXR agonist) in Chronic Hepatitis B and in NASH.
Several additional innovative drug discovery programs are progressing speedily towards non-Clinical Development; their human targets being yet untapped by Pharma’s, these programs can moreover be developed for various indications (metabolic diseases, oncology…).
Levée de fonds, recrutement, partenariat, cession, recherche de locaux : publiez votre opportunité gratuitement et touchez la communauté French Tech.
+ Déposer une annonce Gratuit, vérifié avant publication. Voir les annonces en lignePublicité
Orpailleur de Pépites French Tech